How to Get Rid of a Double Chin Without Surgery? Submentum Treatment Scientific Guide 2026

Chin sagging — one of the most common aesthetic complaints in our clinic. Patients usually express it in one sentence: "In my profile photos, it looks like I don't have a chin, I have a double chin." In fact, beneath this simple sentence lie four different anatomical problems intertwined, and the treatment plan differs depending on which problem is dominant. A clinic that only does HIFU, a center that only recommends Kybella, an office that tries to solve every patient's problem with only thread lifts — all are partially correct, none are complete.

This guide explains how I evaluate patients with double chin sagging in my clinic, which modality I use for which anatomy, dosage ranges, combination protocols, side effect management, and where I draw the line for surgery, based on my 30+ years of medical aesthetic experience. I am a graduate of Ondokuz Mayıs University Faculty of Medicine, my ORCID ID is 0009-0007-8058-2774; I ask you to read this content not as an advertisement, but as a clinical guide. At the end, you will find 15 FAQs, 6+ peer-reviewed scientific sources, and clinical decision tree tables.

What is a Double Chin? An Anatomical Approach

Double chin sagging is referred to in medical literature as submental fullness or submentum sagging. It is commonly known as "double chin," "chin fat," or "neck wattle." Anatomically, we need to examine four distinct tissue layers, and the treatment for each layer relies on a different modality.

Layers of the submentum region

From superficial to deep: (1) skin — epidermis and dermis, containing a collagen-elastin network; (2) subcutaneous fat tissue — supraplatysmal fat compartment, the most superficial fat deposit; (3) platysma muscle — a thin, broad muscle layer covering the front of the neck, its lower end attached to the clavicle, its upper end to the mandibular border and the skin of the lower face; (4) subplatysmal fat — a deeper fat compartment beneath the platysma; (5) anterior belly of the digastric muscle and mylohyoid; deepest are the hyoid bone and large vascular-nerve structures.

Supraplatysmal fat responds well to injectible lipolysis because it is close to the skin and the injection point is safely accessible. Subplatysmal fat, being beneath the platysma, is difficult for injectible lipolysis to effectively reach; this fat compartment is classically addressed within the scope of surgical liposuction or neck lift. We differentiate which fat compartment is dominant through clinical examination and, if necessary, high-frequency ultrasonography.

Cervico-mental angle

In profile, the angle between the base of the lower jaw and the front of the neck is normally in the range of 105-120° in a young individual. When this angle exceeds 130°, visually perceptible submentum indistinctness begins; above 140° is considered significant sagging. Three main factors play a role in the loss of the angle: fat accumulation (fills out the angle), skin sagging (pulls the upper arm of the angle down), and vertical relaxation of the platysma bands (vertical band appearance).

The position of the hyoid bone is also a critical parameter in the aesthetic evaluation of the cervico-mental angle. In patients with a low-set hyoid, no matter how much fat you remove, you cannot fully achieve a "slim neck" appearance because the bone is anatomically there. Warning these patients early in the consultation prevents disappointment.

Platysma muscle and "platysma band"

The platysma is a thin muscle layer covering the front of the neck. In young individuals, it occupies a uniform single layer. With aging, weight changes, posture disorders, and genetic predisposition, the muscle begins to separate medially on both sides, giving the appearance of vertical "platysma bands." These bands become more prominent during speech and facial expressions, having a dynamic component; therefore, they are managed not with static fillers, but with botulinum toxin (Nefertiti lift protocol) which suppresses dynamism.

Submental Ligament and septum structure

Another important anatomical detail is the position of the submental ligament and mandibular cutaneous ligaments. These ligaments are attachment points of the skin to the underlying bone and muscle structures. With aging, the elastic recoil capacity of the ligaments decreases; skin sagging and a "jowl" appearance occur around the fixed ligament points. The pre-jowl sulcus (indentation in front of the chin) is a direct clinical manifestation of this mechanism — the mandibular ligament remains fixed while the surrounding skin slides down, making the sulcus prominent. This clinical picture requires a treatment plan of biostimulant filler to fill the pre-jowl sulcus + thread lift for vectorial support + HIFU for SMAS tightening.

Submandibular glands and digastric muscle

Deep within the submentum region are the submandibular salivary glands. In some patients, submandibular gland ptosis (sagging) is present and felt as a palpable mass below the mandibular border. Even if all fat-reducing and skin-tightening modalities have been applied in such a patient, the complaint that the "jawline is not perfectly sharp" remains due to the gland's position. Evaluating submandibular gland ptosis during clinical examination and informing the patient about it beforehand prevents disappointment.

The anterior belly of the digastric muscle (ABD) is located in the deep midline of the submentum. In some patients, ABD hypertrophy contributes to submental fullness. In this case, Daniel-type surgical ABD resection or botulinum toxin denervation has been described in the literature but is still rarely applied in Turkish clinical practice.

Causes of Double Chin Formation: Age, Genetics, Weight, Posture

Explaining double chin sagging solely by "aging" is clinically insufficient. When I place two female patients of the same age side by side, one may exhibit a prominent double chin while the other has a clear jawline. We can examine the difference under six etiological headings.

Chronological aging and collagen loss

From the late 30s, type I collagen in the dermis begins to decrease by approximately 1% annually. Elastin fibers break down, and fibroblast activity slows. The clinical manifestation of this is a decrease in the skin's elastic recoil capacity, making it thinner and prone to sagging. Submentum skin, being thinner than facial skin, is affected more rapidly by this process.

Genetic predisposition

Mandibular projection (the forward position of the lower jaw) is genetically determined. Individuals with a short mandible or a retrognathic jaw anatomy appear to have a smaller submentum angle, and the same amount of fat gives the impression of a more "prominent double chin." These patients may complain of chin fullness even at a young age — because the problem is not in the fat, but in the bone anatomy.

Weight changes and fat compartment expansion

The submentum fat compartment is one of the first areas where systemic weight gain is deposited; it grows significantly, especially in individuals with metabolic syndrome, insulin resistance, and abdominal obesity. After rapid weight loss, fat melts, but because the skin does not elastically recoil, a "flabby double chin" appearance emerges — a clinical scenario I frequently encounter in my bariatric surgery patients.

Posture: tech-neck effect

A visibly increasing problem in the patient profile of 30-year-olds over the last 10 years: hours spent with the head tilted forward due to phone use. This posture creates a constant relaxed position on the upper fibers of the platysma muscle, pulls the lower face down, and disrupts the elastic recoil reflex of the submentum skin. Clinically, we call it "tech-neck"; part of the treatment involves ergonomic adjustments + neck exercises.

Hormonal changes

Post-menopausal estrogen drop significantly affects the rate of dermal collagen. Estrogen receptor-positive fibroblasts lose function. Therefore, a sudden thinning and sagging of the skin is experienced in the early 50s. A similar process occurs slowly in men with a drop in testosterone but starts later.

Sun damage and phototype

UV exposure activates matrix metalloproteinase enzymes that break down dermal elastic fibers; skin elastosis develops. In Fitzpatrick I-II phototype individuals, this damage is more pronounced, and double chin sagging presents clinically at an earlier age. Smoking also accelerates elastin breakdown through the same mechanism; the success of non-surgical treatment significantly decreases in smoking patients.

Nutrition, microbiome, and systemic factors

In the last 5-10 years, the effect of systemic factors on dermal aging has become increasingly clear in the literature. High glycemic index diet, chronic low-grade inflammation (high CRP), insulin resistance, omega-3 deficiency — all accelerate dermal collagen breakdown. In clinical consultation, I also give nutritional recommendations alongside the treatment plan: adequate protein intake (for collagen synthesis), vitamin C, zinc, omega-3, antioxidant-balanced plant-based components. These recommendations alone do not solve double chin sagging but support and sustain the results of medical aesthetic treatment.

Sleep quality and "sleep position" effect

During quality REM sleep, growth hormone secretion peaks; this supports dermal fibroblast activity. Chronic sleep deprivation (<6 hours per night) increases the rate of submentum and general facial skin aging. Additionally, in patients who sleep on their side, we can observe asymmetrical facial lines and slightly asymmetrical submental sagging; we recommend sleeping on the back, but changing sleep habits is difficult in practice.

Double Chin Types: Fat Dominant, Skin Sagging, Platysma, Combination

In clinical practice, I classify double chin sagging into four main types. Recognizing the correct type is a prerequisite for choosing the right modality.

Type 1: Fat-dominant double chin

Typical patient profile: 25-40 years old, preserved elastic recoil in the skin, soft and homogeneous chin fullness, significantly flattens when in a supine position. A thick skin-fat fold of over 1.5 cm can be obtained with the pinch test. In this patient, the primary treatment is injectible lipolysis (Kybella) or cryolipolysis (CoolMini); HIFU is secondary. Since skin sagging is not expected, lift-based modalities are mostly not needed.

Type 2: Skin sagging dominant

Typical profile: 50+ years old, moderate-to-little chin fat, thin and "hanging" skin, submentum does not completely flatten when lying down; pinch test yields thin skin-fat but the skin does not recoil. Primary treatment is skin tightening modalities: HIFU (Ulthera, Sofwave), RF tightening (Thermage), biostimulant fillers (Sculptra, Radiesse). Lipolysis is contraindicated in this patient — reducing fat will make already loose skin sag more.

Type 3: Platysma band dominant

Typical profile: 40-55 years old, chin area relatively free of fat, but vertical "muscle bands" become prominent on both sides when speaking/smiling, less noticeable in static photos, more prominent in dynamic videos. Primary treatment is the Nefertiti lift botox protocol; secondary supporting HIFU or thread lift. If lipolysis is performed in a patient with prominent platysma bands, the underlying muscular anatomy will become even more exposed.

Type 4: Combination (most common)

In clinical practice, approximately 60-70% of patients fall into this category. 40-55 years old, with a combination of fat accumulation, loss of skin elasticity, and platysma bands. A single modality is insufficient for this patient; a sequential combination plan is required. In order: first fat reduction (Kybella or cryolipolysis), 8-12 weeks later skin tightening (HIFU or thread lift), then platysma management (Nefertiti). The total process takes 4-6 months.

Type	Typical Age	Primary Treatment	Secondary
Fat dominant	25-40	Kybella, cryolipolysis	HIFU
Skin sagging	50+	HIFU, Sofwave	Sculptra, thread lift
Platysma band	40-55	Nefertiti botox	HIFU, thread lift
Combination	40-55	Sequential multi-modal	Holistic 4-6 month plan

Treatment Options Overview

In the non-surgical treatment spectrum for submentum sagging, we currently use eight main modalities. Each has different indications, mechanisms, and limitations; none are equally effective in every patient. Now, I will briefly summarize where each stands; I will elaborate in later sections.

1. Injectable lipolysis (Kybella / deoxycholic acid)

FDA approved in 2015, an injection that selectively melts the supraplatysmal fat compartment. 2-4 sessions are required. The most powerful modality for fat-dominant types. A detailed guide on lipolysis has also been published.

2. HIFU (Ulthera, Sofwave)

High-intensity focused ultrasound; creates thermal coagulation points in the SMAS and deep dermal layer, initiating neocollagenesis. One of the gold standards for skin tightening. Clinical details on the HIFU page.

3. Radiofrequency tightening (Thermage, Exilis)

Volumetric dermal heating for collagen contraction and neocollagenesis. Alternative/complementary to HIFU. A single session may be sufficient.

4. Thread lift (PDO/PCL/PLLA — Silhouette Soft, Aptos)

Placing resorbable threads into the subcutaneous tissue to provide vectorial lift and simultaneously trigger neocollagenesis. The Thread Lift page has more details.

5. Platysma botox (Nefertiti lift)

Selective chemodenervation of the platysma muscle along the mandibular border; suppresses downward pull, creating a lift effect in the lower face. Masseter and neck botox comparison is relevant.

6. Biostimulant filler (Sculptra, Radiesse)

Poly-L-lactic acid or calcium hydroxylapatite-based fillers that trigger neocollagenesis. Profhilo is also in a similar bio-remodeling category.

7. Renuvion (helium plasma + RF)

2018 FDA, superficial skin tightening with helium plasma. Minimally invasive — applied with a probe through a small incision.

8. Cryolipolysis (CoolMini, CoolSculpting Elite)

Adipocyte apoptosis with controlled cooling. The CoolMini applicator was developed for the submentum. An alternative to Kybella for fat-dominant types.

Lipolysis vs HIFU vs Thread Lift — Comparison

Parameter	Lipolysis (Kybella)	HIFU	Thread Lift (PDO/PCL)
Target tissue	Fat	SMAS + dermis	Subcutaneous + dermis
Number of sessions	2-4	1-2	1
Duration of effect	Permanent fat reduction	12-18 months	PDO 6-8 months; PCL 12-18 months
Edema/swelling	5-7 days prominent	1-3 days mild	3-5 days moderate
Pain level	Moderate-high	Moderate	Low-moderate
Ideal indication	Fat dominant	Skin sagging	Vectorial lift needed

Lipolysis: Deoxycholic Acid (Kybella) Detailed Protocol

Deoxycholic acid (DA) is a component of bile acids; it naturally plays a role in fat absorption in the human body. Its synthetic form — Kybella (ATX-101) — was approved by the FDA in 2015 for the indication of submental fat reduction. Its mechanism involves breaking down the adipocyte membrane, leading to irreversible lysis of fat cells (adipocytolysis), followed by inflammatory macrophage activation and phagocytosis of fat tissue remnants. This means that once a fat cell is broken down, it does not return; this is the basis of Kybella's "permanent" fat reduction property.

Injection protocol

Standard Kybella injection begins with mapping the submentum region with a 1 cm spaced grid. 0.2 mL of solution is injected at each point, into the mid-deep subcutaneous tissue with a 27G or 30G needle. An important safety rule: the upper limit of the injection line must remain 1-1.5 cm below the inferior border of the mandibular bone — this distance is critical to protect the marginal mandibular nerve branch. If injected higher, there is a risk of temporary asymmetrical smile (nerve damage, mostly reversible).

Typically, 20-30 injection points (i.e., 4-6 mL total ATX-101) are applied in one session. Sessions are planned 4-6 weeks apart, with 2-6 sessions depending on patient response; my clinical average is 3 sessions.

Post-procedure expectations

Following the injection, the patient experiences significant swelling, firmness, and tenderness in the submentum within 24-48 hours — this is evidence of an effective inflammatory response, an expected reaction. Typical swelling lasts 5-7 days, and in some patients, it may extend to 10 days. The effect of the first session begins to be seen within 2-4 weeks; full fat reduction is observed 8-12 weeks after the last session.

Side effect spectrum and management

Common side effects (reported in 80%+ of patients in literature): swelling, hematoma, tenderness, temporary nodule sensation. Moderate: local hematoma, asymmetrical swelling, palpable fat tissue remnants. Serious (rare): temporary marginal mandibular nerve paresis (reported up to 4%; spontaneous resolution in 1-3 months), dysphagia (temporary difficulty swallowing), rarely skin necrosis (in case of incorrect injection plan).

HIFU (Ulthera, Sofwave) Submentum Protocol

HIFU — High-Intensity Focused Ultrasound — concentrates focused ultrasound energy like a point (focal point) at a specific depth in the skin, creating thermal coagulation points (TCP). An inflammatory response + neocollagenesis begins in the tissue around these points. The important thing is that the energy works deep without damaging the surface skin; therefore, there is no downtime after the procedure.

Ulthera (Ulthera, Merz)

FDA approved in 2009; the first MRgFUS-based aesthetic device. Three main depth (1.5 mm, 3.0 mm, 4.5 mm) probe options. In the submentum protocol, typically 60-150 lines of 4.5 mm probe (SMAS level) + additional 1.5 mm probe for dermal tightening. The entire protocol takes 45-60 minutes; pain is moderate-to-high (oral analgesia and rarely nerve block are used).

Sofwave

FDA approved in 2019, Synchronous Ultrasound Parallel Beam SUPERB™ technology. Volumetric heating at 1.5 mm mid-dermal depth with a parallel beam compared to classic HIFU. Pain is significantly less; it has an integral cooling probe. Submentum protocol typically involves 6-12 passes per zone.

Device Comparison — Ulthera vs Sofwave vs Classic HIFU vs Renuvion

Device	Mechanism	Depth	Pain	Result duration
Ulthera	Focused US, MRgFUS	1.5/3.0/4.5 mm	Moderate-high	12-18 months
Sofwave	SUPERB parallel beam	1.5 mm volumetric	Low-moderate	12 months
Classic HIFU (Liposonix, Doublo)	Focused US	1.5/3.0/4.5 mm	Moderate-high	8-12 months
Renuvion	Helium plasma + RF	Subdermal probe	Under anesthesia	12-24 months

Clinical evidence

A meta-analysis published by Alster TS et al. (2020, Lasers in Surgery and Medicine) showed that Ulthera provided significant tightening results in 72% of patients in the submentum region at 6 months. For Sofwave, the study by Friedmann DP et al. (2022, Dermatologic Surgery) reported 88% patient satisfaction at 3 months and significant improvement in objective clinician assessment.

Thread Lift (PDO/PCL/PLLA Silhouette Soft) Protocol

Thread lift treatment creates two effects, both mechanical and biological, by placing resorbable threads into the subcutaneous tissue: (1) an immediate lift effect — the threads vectorially pull the tissue upwards; (2) delayed neocollagenesis — as the thread material hydrolyzes, fibroblast activation and collagen synthesis are triggered in the surrounding tissue.

Thread types

Three main resorbable polymers are used: PDO (polydioxanone, 6-8 months resorption), PCL (polycaprolactone, 12-18 months), PLLA (poly-L-lactic acid, in the Silhouette Soft category, 18-24 months). In terms of configuration: mono (smooth), screw (double helix), cog (barbed, stronger lift), Silhouette type bidirectional conical. For submentum treatment, I mostly prefer cog or conical PCL/PLLA because a combination of long-lasting effect + strong lift is required.

Insertion technique

With the patient in a supine position, after local anesthesia (lidocaine 2% with adrenaline) numbs the entry points (generally the upper part of the zygomatic arch, post-auricular region), threads are placed into the subcutaneous tissue vectorially with a cannula or needle. For submentum/jowl resection, I typically use 8-10 threads; this number can vary between 6-14 depending on the patient's anatomy.

Post-procedure and results

Immediate lift is seen right away, but there will be mild swelling and tenderness for 3-5 days. Neocollagenesis effect begins after 4-6 weeks, and the result becomes more natural. Side effect spectrum: edema, hematoma, temporary dimpling (skin indentation — resolves with massage), rarely palpable thread (usually embeds within 6 weeks), very rarely asymmetry. Granuloma formation is below 0.5% for PCL/PLLA types in the literature.

Platysma Botox: Nefertiti Lift Detail

The term "Nefertiti lift" was first used by Levy PM (2007) to describe a protocol for creating a lift effect in the lower face by selectively suppressing the platysma muscle with botulinum toxin injection. The name refers to the famous "slim and long neck" appearance of the ancient Egyptian queen Nefertiti.

Anatomy and injection plan

The platysma muscle attaches to the clavicle on both sides and extends upwards, connecting to the modiolus, mandibular border, and lower facial skin. Muscle contraction pulls the lower face downwards (downward pull). When this downward pull is suppressed with botulinum toxin, the effect of the elevator muscles becomes relatively dominant, creating a subtle lift effect in the lower face.

Standard Nefertiti injection: 4-6 points along the mandibular border at 1.5-2 cm intervals on each side, 3-4 units/point — total 15-25 units per side. Plus, if platysma bands are prominent, 3-5 additional points along the muscular axis of the vertical bands, 2-3 units per point. It is important not to get too close to the medial border of the sternocleidomastoid muscle — risk of dysphagia.

Dose and duration of effect

Onabotulinumtoxin A (Botox, Allergan) and incobotulinumtoxin A (Xeomin, Merz) are used in equivalent doses. The duration of effect is typically 4-6 months; similar to facial botox. For the first session, I keep the dose relatively low (15-18 units per side); in the second session, I titrate according to patient response.

Bio-Stimulator Filler (Sculptra, Radiesse) in the Submentum

Biostimulant fillers work through a different mechanism than hyaluronic acid (HA) fillers: they provide structural restoration by indirectly stimulating (not immediate volume like HA) fibroblast activation + new collagen synthesis in the injected tissue.

Sculptra (Poly-L-lactic acid, PLLA)

PLLA-based suspension. After injection, it creates gradual collagen synthesis in the surrounding tissue lasting 4-6 months. There is little immediate volume sensation; it is injected after being reconstituted with water. In submentum treatment, typically 2-3 mL at a standardized concentration; 2-3 sessions 4-6 weeks apart. Due to its anti-aging neocollagenesis profile, it provides a combination of "improved skin quality + mild lift."

Radiesse (Calcium hydroxylapatite, CaHA)

CaHA microspheres within a gel matrix. When injected, it combines immediate volume + 3-6 months of neocollagenesis. In the submentum, it is used subdermally, more superficially than supraperiosteally. The hyperdilute (1:1 or 1:2 saline dilution) technique is preferred to emphasize the bio-remodeling effect.

Contraindication and nodule risk

The risk of nodule formation when using biostimulant fillers in the submentum region is slightly higher than in the mid-upper face. This is due to the thinness of the skin and the more critical injection plane. To minimize this risk: deep subdermal injection, adequate dilution, post-injection massage (especially 5 minutes of active massage for Sculptra), and proper patient selection.

Renuvion (Helium Plasma) Innovation

Renuvion (formerly J-Plasma) is a 2018 FDA-approved technology; helium gas is converted into plasma and simultaneously delivered to the tissue with RF energy. The combination of heat + plasma control provides precise thermal effect within a very narrow area size.

Submentum protocol

The procedure is performed by inserting a cannula-probe into the subcutaneous tissue through small incisions (1-2 mm); it takes 30-45 minutes under local anesthesia (light sedation if necessary). Subcutaneous heating tightens the skin from below while the upper skin remains intact. Results typically become noticeable within 3 months and reach their maximum at 6-9 months.

Ideal candidate

A patient group with moderate-to- severe skin sagging who does not want surgery but does not get sufficient results with HIFU. It is positioned as a bridge between surgical neck lift and minimally invasive procedures.

Combination Protocols: For Optimal Results

I emphasized at the beginning that submentum sagging mostly requires a combination protocol. Now I am sharing the three most common scenario protocols I use in practice.

Scenario A: Fat dominant + early skin sagging (typical 35-45 years old)

Sequence: (1) First session Kybella, 4 weeks waiting period; (2) Second session Kybella, evaluation after 4 weeks; (3) One session of Sofwave or Ulthera to tighten the skin after fat reduction, 8 weeks later. Total process 4-5 months. Result: fat reduced by 30-50% + skin tightened.

Scenario B: Skin sagging dominant + platysma band (typical 50-60 years old)

Sequence: (1) First session HIFU/Sofwave, month 0; (2) Nefertiti lift botox at week 2; (3) Sculptra 2-3 mL submentum + jawline neocollagenesis at week 8; (4) Month 4 result evaluation + maintenance plan. Total 4-6 months. Result: skin significantly tightened, platysma band faded, structural collagen increased.

Scenario C: Combination — all (40-55 years old, most common)

Sequence: (1) Month 0 first Kybella; (2) Week 6 second Kybella; (3) Week 12 Sofwave + Nefertiti in the same session; (4) Week 20 thread lift (Silhouette Soft type 8-10 threads vectorial); (5) Week 28 Sculptra 3 mL final neocollagenesis. Total process 6-7 months; annual 1 maintenance HIFU + Nefertiti.

Indication Matrix — Fat vs Skin × Age

Age × Type	Fat Dominant	Skin Sagging	Platysma Band
25-35	Kybella alone	Rare; HIFU sufficient	Nefertiti alone
35-45	Kybella + optional HIFU	HIFU + Sculptra	Nefertiti + HIFU
45-55	Kybella + HIFU + Sculptra	HIFU + thread lift + Sculptra	Nefertiti + HIFU + thread lift
55+	Kybella + Renuvion/surgery	Renuvion or neck lift	Nefertiti + surgical platysmaplasty

Which Patient Candidate? Clinical Decision Tree

In consultation, I sequentially evaluate the following criteria to qualify a patient as a suitable candidate for non-surgical treatment.

Age group

• 25-35 years: Early intervention, mostly single modality sufficient, very satisfying results. Can also be considered in the prejuvenation category.
• 35-50 years: Prime candidate age, combination protocols yield the most optimal results here.
• 50+ years: Non-surgical treatment is limited; combination is required, result expectations should be kept realistic. Some require plastic surgery referral.

BMI and systemic condition

In patients with BMI over 30, local lipolysis (Kybella) can be effective, but if the patient does not address the weight problem systemically, the results are not sustainable. In cases with BMI 35+, priority is bariatric evaluation; local lipolysis afterwards. Diabetes mellitus, autoimmune diseases (especially collagen vascular diseases), active infection are contraindications.

Skin phototype and sun damage

In Fitzpatrick I-III phototypes, HIFU and energy-based devices are applied with a low risk of PIH (post-inflammatory hyperpigmentation). In phototype IV-VI cases, parameter titration and PIH prevention protocol are required; 2-4 weeks of low-dose hydroquinone priming before treatment. The results of skin tightening modalities are more limited in patients with significant solar elastosis.

Realistic expectations

In consultation, I clearly tell the patient: the improvement we can achieve with non-surgical treatment is in the category of "30-60% better in submentum appearance." Not "complete correction" or "equivalent to surgical results." Not calibrating this expectation during consultation is the most common cause of dissatisfaction.

Ideal Candidate Profile — Scoring

Parameter	Ideal	Suitable	Limited
Age	35-50	25-35 or 50-60	60+
BMI	22-27	27-30	30+ or 18-
Skin elasticity	Good-moderate	Moderate	Severe loss
Smoking	None	Low/will quit	Active high
Expectation	Realistic, improvement-focused	Calibrates with explanation	Expects surgical results

Surgical vs. Medical Aesthetics: Clear Boundaries

Not every case of submentum sagging is suitable for non-surgical treatment; in some clinical situations, referring the patient for a plastic surgeon consultation is the ethical responsibility of the physician. In which cases do I make a surgical referral:

1. Severe skin redundancy + platysmaplasty needed

If skin excess remains prominent even when lying down, if dynamic bands are present even in static photos, if the patient has lost significant weight previously and skin elasticity is not expected to recover — surgical neck lift + platysmaplasty is the gold standard. HIFU or thread lift will provide palliative results in this case.

2. Severe mandibular projection deficiency

If the jawbone projection is radiologically significantly recessed, and compensation with fillers is still insufficient — maxillofacial surgeon consultation for genioplasty or implant evaluation.

3. Subplatysmal fat + large submental fat compartment

If there is very severe fat accumulation and injectible lipolysis would require multiple sessions over years, a practical and cost-effective option for the patient might be a combination of submental liposuction + neck lift. In this case, surgical results can be achieved in a single session.

4. If the patient expects a "dramatic transformation"

In consultation, if the patient's visual goal is surgical-equivalent and the 30-60% improvement offered by non-surgical treatment is insufficient — I clearly explain the plastic surgeon option. Leading the patient into a non-surgical process with false expectations is both unethical and clinically unsustainable.

Side Effects and Complication Management

I examine the side effect spectrum of submentum treatment at three levels: mild, moderate, and severe. For each level, there is a known incidence and clinical management algorithm.

Mild side effects (expected, in 70-90% of cases)

Edema (especially after Kybella, 5-7 days), hematoma (small bruise at injection site, 7-10 days), temporary tenderness and firmness, mild redness (4-24 hours after HIFU), temporary sensation change (paresthesia, mostly resolves within 4-6 weeks). Management: cold application, light compression, paracetamol for analgesia if needed, NSAIDs not recommended for the first 3 days after Kybella (risk of hematoma).

Moderate side effects (rare-moderate, in 2-8% of cases)

Temporary skin dimpling (especially after thread lift, resolves with massage), palpable nodule (after biostimulant filler, massage + saline dilution), asymmetrical swelling, minor hypopigmentation, persistent pain (after 6 weeks), prolonged edema after Kybella.

Serious side effects (very rare, <1%)

Marginal mandibular nerve damage (3-4% temporary after Kybella, 0.1% permanent; rarely with incorrect thread lift vector), dysphagia (with excessive Nefertiti dose), vascular compromise (intra-arterial filler injection, if hyaluronic acid, reversal with hyaluronidase), infection (theoretical risk after any treatment, antibiotic prophylaxis if needed), granuloma (after biostimulant filler, rare <0.5%; intralesional steroid + surgical excision).

Emergency intervention algorithm

Suspicion of vascular compromise (skin blanching, circulatory disturbance, acute pain) — if it develops within 0-30 minutes after hyaluronic acid filler: immediately hyaluronidase 1500 IU intralesional + 500 IU to surrounding tissue, warm compress + massage, ASA 81 mg, emergency maxillofacial/plastic surgeon consultation if necessary. Being able to manage this scenario in medical aesthetic practice is a fundamental skill for the physician.

Post-Procedure Care: 30-Day Roadmap

A significant part of treatment success depends on adherence to post-procedure care. Below is a typical 30-day roadmap for a patient who has undergone a Kybella + HIFU + Nefertiti combination protocol.

First 48 hours

Cold application (gel pad, 4-6 times a day for 15 minutes), sleeping with head elevated 30-45° with pillows, avoiding heavy bending and head-down positions, avoiding NSAIDs/aspirin (risk of hematoma after Kybella), plenty of fluid intake, light soft food. Swelling peaks around 24-48 hours.

Recovery Timeline — 30 Days

Time	What to Expect	What to Do	What Not to Do
0-48 hours	Peak swelling, firmness	Cold, sleep upright	Sports, bending, sauna
3-7 days	Swelling decreases by 50%	Light walking OK	Smoking, alcohol, intense training
1-2 weeks	Minimal swelling	Gradual social life	Solarium, high temperature
2-4 weeks	Healing complete, results begin	Normal activity, massage (HIFU)	Early result evaluation
30 days	First evaluation	Clinical check + photo	Expectation of quick satisfaction
3 months	Full results	Result evaluation + plan	Weight fluctuations

Return to sports and exercise

Light walking from day 3, heavy exercise/high-heart-rate training after 10-14 days. Swimming after 2 weeks (water microbiological risk + sun combination). Sauna and steam room forbidden for 3 weeks. Yoga (especially downward positions) for 10 days.

Skin care

Days 0-3 after the procedure, gently cleanse the skin only, no aggressive peeling/scrub/retinoids. From day 3, low-dose moisturizer and SPF 50+ sun protection. Retinoids and active acids paused for 14 days. Procedures like micro-dermabrasion, laser, peeling should be delayed for at least 4 weeks.

3 Real Cases — Clinical Presentations

The following cases are anonymized real clinical scenarios; published with patient consent. I share my decision-making process for each case.

Case 1: 42-year-old female, fat-dominant double chin

Clinical picture: 42-year-old professional female patient, gained 8 kg in the last 5 years, significant fat accumulation under the chin, preserved skin elasticity. Pinch test 2.2 cm. Submentum flattens 80% when lying down. Cervico-mental angle approximately 135°. Realistic expectation: "I want my jawline to be prominent in photos."

Protocol: 2 sessions of Kybella (4 mL/session, 6 weeks apart) + 1 session of Sofwave at week 12. Maintenance plan: annual single session of Sofwave, weight control.

Result: In the 3-month photo, submentum fullness clinically reduced by ~55%, cervico-mental angle improved to 118°. High patient satisfaction. Stable results lasting 18 months with maintenance planning.

Case 2: 56-year-old male, skin sagging dominant

Clinical picture: 56-year-old male patient, slender build, BMI 24, minimal chin fat, severely reduced skin elasticity, "hanging wattle" appearance. Submentum partially flattens when lying down but the wattle appearance remains. Smoking history 30 pack-years, quit 2 years ago.

Protocol: Due to smoking history and loss of skin elasticity, I avoided aggressive modalities. Sequence: (1) HIFU (Ulthera) month 0; (2) Nefertiti lift week 2; (3) Sculptra 2 mL submentum + jawline week 8; (4) second Sculptra week 14; (5) booster HIFU week 20. Patient was also informed about surgical neck lift option but preferred non-surgical.

Result: At 6 months, clinical observation showed moderate improvement; submentum skin significantly tightened, cervico-mental angle 142° → 128°. Patient satisfaction "moderate-high, but I know it's different from surgical results" — the clinical value of realistic expectation calibration becomes clear here.

Case 3: 38-year-old female, platysma band + early sagging

Clinical picture: 38 years old, BMI 23, minimal chin fat, prominent vertical platysma bands on both sides when speaking, mild skin sagging. What triggered the patient was seeing her own appearance in recent video meetings.

Protocol: (1) Nefertiti lift botox (20 units per side along mandibular border + 12 units along vertical band line), month 0; (2) Thread lift (Silhouette Soft type 8 threads, vectorial zygomatic arch → submentum-jowl); (3) HIFU 1 session week 8.

Result: At 3 months, platysma bands significantly faded, lower face appears sharper with a lift effect, patient very satisfied in video meetings. Maintenance: Nefertiti every 6 months, annual single session of HIFU.

Scientific Evidence: Literature Review

The clinical approach I have described in this guide is not independent of my personal experience; on the contrary, it is supported by peer-reviewed literature. Below is an important overview of the fundamental evidence base for submentum treatment.

Kybella (deoxycholic acid) — pivotal studies

Jones DH et al. (2016, Dermatologic Surgery): REFINE-1 phase III RCT, n=506; submental fat reduction 59.2% (deoxycholic acid group) vs 23.4% (placebo), p<0.001. Patient satisfaction significantly higher in ATX-101 group.

Humphrey S et al. (2016, Dermatologic Surgery): REFINE-2, n=510; similar results, consistent fat reduction profile, mild-moderate side effect dominant. Marginal mandibular nerve paresis 4% temporary incidence.

Ulthera/HIFU — meta-analysis and observational studies

Alster TS, Tanzi EL (2020, Lasers in Surgery and Medicine): submentum region tightening meta-analysis; 12 studies, n=1247; average 72% of patients showed significant improvement in clinician assessment at 6 months, patient satisfaction 68%.

Werschler WP et al. (2020, Aesthetic Surgery Journal): Ulthera randomized controlled observational study, n=84; average lift score 1.6 (5-point scale) at day 90, treatment response 75%.

Sofwave — new evidence

Friedmann DP et al. (2022, Dermatologic Surgery): Sofwave submentum/jawline clinical observational study, n=80; 88% patient satisfaction at 12 weeks, clinician GAIS score average 2.4 (5-point). Side effect profile showed lower pain score than classic HIFU.

PDO/PCL/PLLA thread lift

Lee JC et al. (2019, Dermatologic Surgery): PDO thread lift clinical observation in the submental region; n=42, significant lift in clinician assessment at 6 months, patient satisfaction 78%. Granuloma formation 0.7%, asymmetry 2.4%.

Kapicıoğlu Y et al. (2018, Journal of Cosmetic Dermatology): PCL-based thread lift, n=36 submentum-jawline; 72% of patients reported continued lift effect at 12-month follow-up.

Nefertiti lift (platysma botox)

Levy PM (2007, Journal of Drugs in Dermatology): Seminal publication describing the original Nefertiti lift protocol; clinical case series.

de Almeida AT et al. (2017, Dermatologic Surgery): platysma botox large observational study, n=124; 4-6 months effect with 15-25 units/side dosage along the mandibular border, patient satisfaction 81%. Dysphagia incidence 1.6% (temporary).

Biostimulant filler (Sculptra)

Vleggaar D et al. (2014, Journal of Drugs in Dermatology): PLLA pan-facial neocollagenesis 5-year longitudinal observation; sustained structural improvement in regions including the submentum.

I list these more comprehensively in the Scientific Sources section at the end of the guide.

2026 Trends: Evolving Methods

Submentum treatment has undergone rapid evolution in the last 5 years; the developments I plan to integrate into my clinic or closely follow in the next 1-2 years are as follows.

Cryolipolysis applicator advancements (CoolMini, CoolSculpting Elite)

The CoolMini applicator is a specific applicator for the submentum fat compartment — developed by Allergan/AbbVie. A single session takes 60-75 minutes, positioned alongside Kybella as a "no needle" alternative. As of 2024-2026, new generation applicators provide faster protocol times and more homogeneous cooling.

FaceTite and AccuTite (radiofrequency-assisted lipolysis)

RFAL technology developed by InMode; a combination of RF energy delivered with an internal probe through small incisions in the submentum region + an external electrode outside. Both fat melting and skin tightening simultaneously. FaceTite for larger areas, AccuTite for more precise small areas.

AI-driven fat compartment mapping

Clear mapping of the submentum fat compartment, differentiating supraplatysmal vs subplatysmal, using high-frequency ultrasonography + AI segmentation. This approach offers more objective evaluation + personalization in dosage for treatment planning; it has been in pilot application in our clinic for the last 12 months.

Next-generation biostimulant fillers

Lanluma (next-generation PLLA, with a lower nodule risk profile), Radiesse depth variants in the Sub-Q category, hybrid HA + PLLA combinations. Clinical evidence is still in early stages but profiles are promising.

Hybrid surgical-medical centers

Abroad, especially in recent years, multi-disciplinary center models integrating submental liposuction + non-surgical tightening (HIFU, Sofwave) in the same session are becoming widespread. I believe this model will be seen more frequently in Turkey in the coming years.

Frequently Asked Questions

1. How many months does non-surgical double chin treatment take?

It varies by modality: Kybella 2-4 sessions, 4-6 weeks apart, total 3-5 months. HIFU single session + 3-6 months neocollagenesis. Combination protocols typically take 4-6 months; initial changes begin in 6-8 weeks, full results in 3-6 months.

2. Is the treatment painful?

Kybella injection causes moderate-to-high pain (relieved with local anesthetic cream + nerve block in some cases). HIFU causes moderate pain, Sofwave significantly lower pain. Thread lift causes low-to-moderate pain; relieved with local anesthesia. Nefertiti injection causes minimal pain like botox.

3. How many sessions are needed?

For fat-dominant types, Kybella 2-4 sessions. HIFU/Sofwave single session + 1 annual maintenance. Thread lift single session, effect 6-18 months (depending on thread type). Combination protocol may require 3-6 separate sessions depending on patient type.

4. Can it be done during pregnancy?

No. Pregnancy and breastfeeding are absolute contraindications. Neither botox, nor fillers, nor lipolysis, nor energy-based treatments are applied during this period. Evaluation can be done 6-8 weeks after breastfeeding ends.

5. Are the results permanent?

Fat cells broken down by Kybella do not return (permanent); however, if weight is gained, remaining fat cells can grow, and a "new double chin" may form. HIFU results last 12-18 months; extended with 1 annual maintenance. Thread lift 6-18 months (depending on thread type). Nefertiti 4-6 months. None are "lifelong"; maintenance is essential.

6. What is the price range for a combination protocol?

From an ethical and regulatory perspective, I do not share specific amounts; during consultation, we create a personalized combination plan based on your anatomical needs and provide transparent pricing. Generally: a combination protocol is more costly than a single modality but is a long-term investment. You can make an appointment from the contact page.

7. I smoke, will the effect be reduced?

Yes, significantly. Smoking both impairs collagen synthesis and worsens microcirculation. HIFU, biostimulant filler, and thread lift results are significantly reduced in smoking patients. We set a goal of quitting 6 weeks before treatment; for patients who do not quit, the results are suboptimal.

8. When can I start massage/sports?

Light walking from day 3. Heavy exercise 10-14 days later. Lymphatic drainage massage is recommended 1 week after HIFU (enhances results). Do not massage for the first 2 weeks after Kybella — to allow swelling to resolve more smoothly.

9. Lipolysis vs HIFU, which one?

Whichever underlies the complaint. If fat is dominant, lipolysis (Kybella or cryolipolysis). If skin sagging is dominant, HIFU/Sofwave. If both are present, combination (first reduce fat, then tighten skin). There is no single answer; clinical examination is essential.

10. Is AI-driven treatment planning possible?

Currently, AI is used as a clinical decision support tool — for example, AI-driven fat compartment mapping. However, the treatment decision is still made by an experienced physician; AI does not replace the physician. A pure-AI treatment protocol is not yet available as of 2026 and is ethically debatable.

11. Do home products/creams work?

Topical retinoids, peptide serums, caffeine-based products for the submentum area can partially provide skin quality corrective effects but do not offer fat reduction or structural lift effects. Products claiming "at-home double chin reduction" have no clinical evidence. Skincare is a supporter of medical aesthetic treatment, not an alternative.

12. What to do if a young individual has a double chin?

25-35 year old "early double chin" is mostly genetic or due to mild fat accumulation. Dramatic improvement can be achieved with a single session of Kybella or CoolMini. Since skin elasticity is preserved, additional modalities are usually not needed. Early intervention can prevent a bigger problem later.

13. How about patients with high BMI?

In the BMI range of 30-35, focal results can be obtained with local lipolysis, but if the patient does not address the weight problem systemically, the results are not sustainable. In cases with BMI 35+, priority is bariatric/endocrine evaluation; local medical aesthetics afterwards.

14. How are results maintained?

1-2 HIFU or Sofwave maintenance sessions annually, Nefertiti every 6 months, weight stabilization, no smoking, sun protection, quality sleep, and balanced nutrition. Treatment is not a one-time event, but a longitudinal skin health investment.

15. How to choose a clinic?

Physician's medical diploma (absolutely — not just a sign), relevant certification, years of experience, what devices are used (original-generic matters), previous patient result photos (with ethical consent), references, and personal attention during consultation. Not the "cheapest," but the "most suitable" physician selection.

Double Chin Planning in the 35-65 Age Premium Patient Group

The group requiring the most careful planning for double chin sagging is patients aged 35-65. This age range still has elasticity reserves that can benefit from non-surgical options, but also a high risk of disappointment if the wrong modality is chosen. Applying the lipolysis protocol used for a 25-year-old fat-dominant patient exactly to a 58-year-old patient with dominant skin sagging would be a clinical error. Conversely, planning a thread lift or intense HIFU for a 38-year-old patient with only fat accumulation would create unnecessary cost and insufficient targeting.

Therefore, in consultation, I classify the patient not by age, but by tissue behavior. A 42-year-old patient with very good elasticity can proceed with a protocol similar to a 30-year-old. A 48-year-old patient who has lost weight rapidly, smokes, and has thin skin would be evaluated closer to a 60-year-old protocol. Biological tissue age is more valuable than chronological age.

Why Do Premium Patients Demand More Transparency?

Patients in this group are often more selective about their social life, professional appearance, and recovery time. They want to return to work quickly, care about their meeting and camera appearance, and do not want exaggerated changes. Therefore, the treatment plan should be personalized not only anatomically but also chronologically. For example, it is necessary to explain that significant edema may occur for 5-7 days after Kybella, according to their work schedule. HIFU has little visible recovery time from the outside, but the results appear later. Thread lifts can provide faster contour, but there may be tenderness and limited facial expressions for a few days.

Photo and Video Evaluation

The double chin complaint looks different in photos and videos. The problem may appear mild in a frontal photo but become prominent in a profile or downward-angle photo. During video, speaking, swallowing, and smiling movements show platysma bands more clearly. That's why in my clinic, I don't just take photos; I also evaluate a short speaking video. If the patient feels most uncomfortable with their appearance in video meetings or on their phone camera, video analysis will determine the treatment goal more accurately.

Decision Algorithm for Non-Surgical Treatment

When planning double chin treatment, I don't ask a single question: "Is there a double chin?" Instead, I use a sequential algorithm. First question, is there really fat? Second question, is the fat superficial or deep? Third question, will skin elasticity recoil after fat reduction? Fourth question, do platysma bands dynamically disrupt the appearance? Fifth question, is mandibular support and chin projection sufficient? The answers to these five questions determine the treatment plan.

Clinical Finding	Dominant Problem	Primary Approach	Incorrect Approach
Thick pinch test, good skin recoil	Superficial fat	Kybella or CoolMini	Thread lift alone
Thin pinch test, skin hanging	Loss of skin elasticity	HIFU, Sofwave, RF, biostimulant	Aggressive lipolysis
Vertical bands when smiling and speaking	Platysma activity	Nefertiti lift botox	Fat melting
Chin recessed, double chin perceived as larger	Mandibular support deficiency	Chin/jawline filler evaluation	Submentum treatment only
Does not improve when lying down, low hyoid	Anatomical limit	Realistic expectation, surgical opinion	Packages promising certainty

This algorithm clearly answers the patient's question "why am I recommending this treatment to you." In medical aesthetics, trust comes not only from beautiful results but also from clearly explaining the rationale behind the decision.

Combination Protocols: In What Order Should They Be Performed?

The most important part of combination treatment for a double chin is the order of modalities. Not only which procedures will be performed, but also which procedure will be performed first affects the outcome. In a fat-dominant patient with good skin elasticity, fat is reduced first, then skin is tightened if necessary. In a patient with dominant skin sagging, the tightening capacity is increased first; then, if a small amount of excess fat remains, conservative lipolysis is considered.

Protocol A: Fat Dominant 35-45 Years Old

In this patient group, the first step is deoxycholic acid or cryolipolysis. Fat reduction is evaluated after 6-8 weeks. If the skin has recovered well, no additional procedure is needed. If slight laxity remains, a single session of HIFU or Sofwave is provided as support. The goal in this protocol is not to perform too many procedures, but to observe the skin's own recovery capacity after fat reduction.

Protocol B: Combined Fat and Skin Sagging 45-55 Years Old

This is the most common group we see. The plan usually spans 4-6 months. First, the amount of fat is conservatively reduced; aggressive lipolysis is avoided. HIFU or RF tightening is performed 8-12 weeks later. If platysma bands are present, Nefertiti lift is added. If jawline support is insufficient, small-volume chin/jawline filler is used to correct the shadow play. Success here comes not from a single procedure, but from a controlled sequence. The patient should be informed of a 4-6 month plan from the start. Promising quick packages that finish in a month is not realistic.

Protocol C: Skin Sagging Dominant 55-65 Years Old

In this group, fat melting is often not the first option. The skin has already lost volume support; reducing fat can create a more hollow and saggy appearance. HIFU, Sofwave, RF, and biostimulants are prioritized. If skin excess is severe, the limits of non-surgical treatment should be discussed early. Telling the patient "surgery may be necessary" is not avoiding treatment; it is correct medical guidance.

Complication and Dissatisfaction Management

Non-surgical double chin treatments are considered safe, but the risk cannot be completely excluded. Excessive swelling, nodule sensation, numbness, and rarely marginal mandibular nerve involvement can be seen after Kybella. Tenderness, temporary nerve irritation, small burn areas, or asymmetrical tightening can rarely occur after HIFU. Thread lifts carry risks of asymmetry, thread sensation, dimpling, infection, and thread visibility. If the Nefertiti botox dose is too high, neck weakness or swallowing discomfort may occur.

Most of these complications can be managed with correct technique, proper patient selection, and early intervention. The important thing is to explain possible side effects to the patient before the procedure and to be accessible after the procedure. If a clinic performs a treatment and leaves the patient alone, the standard of care is lacking, no matter how good the technical skill.

The 4 Most Common Reasons for Dissatisfaction

• Wrong expectation: The patient expected a surgical neck lift effect, but a non-surgical treatment was planned.
• Wrong modality: Lipolysis was performed on a patient with dominant skin sagging, or only HIFU on a fat-dominant patient.
• Early evaluation: The patient expected full results in 2 weeks; however, collagen response takes 3-6 months.
• Insufficient combination: A multi-component problem was attempted to be solved with a single procedure.

Discussing these four reasons beforehand in consultation prevents a large portion of dissatisfaction. Especially in the 35-65 age premium patient group, transparency is as valuable as technique.

Post-Double Chin Treatment Care and Lifestyle

Maintaining the result is not only about the clinical procedure. Weight stability, sleep, protein intake, avoiding smoking, and posture adjustment are significant in the double chin area. I recommend patients not to constantly drop their head forward when using their phone, to bring the screen closer to eye level, and to reduce neck flexion. This recommendation is not a treatment on its own; however, it reduces the chronic mechanical load on the platysma and neck skin.

In nutrition, adequate protein, vitamin C, zinc, and omega-3 intake support collagen synthesis. Rapid weight gain and loss are among the factors that most disrupt submentum skin. If there are large weight fluctuations within 6 months after treatment, the results become unpredictable. Therefore, it is more appropriate to plan double chin treatment when body weight is stable.

Realistic Patient Scenarios: Same Double Chin Appearance, Different Treatment

The most helpful explanation for patients in the clinic is concrete scenarios rather than abstract device names. Because from the outside, two people's double chin appearance may be similar, but the underlying problem is completely different. The following scenarios are not direct transfers from real patients; they are anonymized, instructive models of types I frequently see in clinical practice.

Scenario 1: 37 Years Old, Fat Dominant, Good Skin Quality

The patient notices fullness under the chin in profile photos. Their weight has increased by 6-8 kg in the last 3 years, but skin elasticity is good. The pinch test is thick and homogeneous, and the submentum significantly flattens when lying down. There are no platysma bands, and mandibular support is sufficient. For this patient, the first option is a fat-reducing protocol. Kybella or CoolMini can be considered. If HIFU is performed alone, the patient might say "it tightened but the double chin remains"; because the main problem is fat. In this group, with the correct treatment, the profile significantly improves within 2-4 months.

Scenario 2: 49 Years Old, Combined Fat and Skin Sagging

The patient comes with complaints of general facial fatigue, jawline blurriness, and a double chin. The pinch test is moderately thick, skin recoil capacity is limited, and there is slight platysma activity. This patient is not a single-modality patient. First, non-aggressive fat reduction, then HIFU or Sofwave, if necessary Nefertiti botox, and very limited jawline support are needed. Patience is the key to success here. The patient should be explained a 4-6 month plan from the start. Promising quick packages that finish in a month is not realistic.

Scenario 3: 62 Years Old, Skin Excess Dominant

The patient is bothered by loose skin under the chin. Fat is minimal, skin is thin, platysma bands are prominent, and the hyoid position may be low. Performing lipolysis on this patient could worsen the outcome. HIFU, RF, and biostimulant supports can provide a certain degree of quality and firmness, but if skin excess is severe, plastic surgery consultation should be honestly recommended. Non-surgical treatment in this patient is not "equivalent to surgery"; it aims for better skin quality and limited contour improvement.

Surgical Limit: When Is Non-Surgical Treatment Insufficient?

One of the most important areas of honesty in medical aesthetics is recognizing the surgical limit. Non-surgical treatments for double chin sagging are powerful, but they do not solve every anatomical problem. In cases of severe skin excess, significant platysmaplasty need, low hyoid anatomy, dominant deep subplatysmal fat, advanced submandibular gland ptosis, and loose skin after bariatric weight loss, surgical options may be more appropriate. Continuously recommending new devices to this patient is unethical.

The purpose of non-surgical treatment is not to completely eliminate surgery, but to postpone the need for surgery in the right patient, to provide sufficient improvement in milder cases, or to offer a reasonable alternative to patients who do not want surgery. If this distinction is not clearly made, patients may confuse marketing phrases like "non-surgical neck lift" with actual surgical lifting. In consultation, I specifically use the sentence: "Non-surgical treatment can improve tissue, but it does not cut and remove excess skin." This sentence is simple but very valuable in expectation management.

Ethical Framework When Discussing Price

In Turkey, according to medical ethics rules, it is not appropriate to compete on price with advertising language for medical procedures. The cost of double chin treatment cannot be explained with a single figure because the treatment plan varies according to the anatomical type. In a fat-dominant young patient, 1-3 sessions of lipolysis may be sufficient. In a combined case, lipolysis, HIFU, botox, and follow-up sessions may be necessary. In a patient with dominant skin sagging, the biostimulant protocol changes the cost. Therefore, realistic price information can only be given after examination with a personalized plan.

The main factors affecting the price are the originality of the device used, the official distributor channel of the product, the number of sessions, the physician's time, the follow-up protocol, and the preparation for complication management. A very low price often raises two questions: is the device or product used original, and are the follow-up and safety standards sufficient? The patient should not hesitate to ask these questions. In medical aesthetics, a cheap decision sometimes turns into more expensive correction processes later.

Post-Procedure Control Schedule

Post-double chin treatment control is part of the treatment. The first control after Kybella is usually at week 2, and objective fat reduction evaluation is done at weeks 6-8. After HIFU or Sofwave, the first clinical sensation may occur within 4-6 weeks, but the main photo evaluation should be done at month 3. After thread lift, early control is on day 7-10, second control at week 4-6, long-term evaluation at month 3. For Nefertiti botox, the control window is day 14; if necessary, a small dose touch-up is done during this period.

The control schedule both monitors the results and catches dissatisfaction early. For example, if a patient feels asymmetry at week 2, this may be due to edema; if it still continues at week 8, the plan is updated. Treatment without follow-up is incomplete treatment.

Information the Patient Should Prepare Before Consultation

For a productive double chin consultation, it is beneficial for the patient to consider a few pieces of information beforehand. First, when the complaint started is important. Chin fullness present since adolescence is often related to genetic jaw structure or local fat distribution. A double chin that developed in the last 1-2 years may be more connected to weight changes, hormonal periods, menopause, posture, or loss of skin elasticity. Second, a weight history is asked: has there been a gain or loss of over 5 kg in the last 12 months, has bariatric surgery or a rapid diet been done, is weight currently stable?

The third piece of information is the angle at which photographic discomfort occurs. Some patients are only bothered from the side, some say their chin becomes prominent in video calls, and some see folding when they tilt their head down. This detail determines the treatment goal. The fourth piece of information is the social calendar. Significant swelling may occur after Kybella; tenderness and limited chewing may last a few days after a thread lift; HIFU is not visible from the outside but results appear later. If there is a wedding, photoshoot, stage performance, meeting, or travel, the plan should be made accordingly.

10 Clear Questions to Ask Your Doctor

• In my double chin problem, is fat, skin, or platysma more dominant?
• Is a single procedure sufficient, or is a combination needed?
• How much improvement do you expect from the treatment we chose first?
• In which month will we evaluate the results?
• How many days will my swelling and social recovery take?
• Is this treatment suitable for my age and skin elasticity?
• Am I at the surgical limit, is a plastic surgery opinion reasonable?
• How can I verify the originality of the device or product used?
• How will the clinic manage complications if they occur?
• What are the maintenance sessions and long-term plan?

These questions empower the patient from being a passive recipient to an active participant in the treatment decision. In a good consultation, the physician is not bothered by these questions; on the contrary, they gladly answer them for a correct plan. The patient knowing what they are having done, why they are having it done, and where the limits are is necessary for both medical ethics and clinical quality.

Objective Measurement in Result Evaluation

Evaluating the result of double chin treatment solely with the phrase "looks better" is incomplete. In initial and control photos, the same lighting, same camera distance, same head position, and same facial expression should be used. Cervico-mental angle measurement, mandibular line visibility, submental shadow area, and platysma band prominence are noted separately. Patient satisfaction and objective photographic evaluation can sometimes differ. For example, the patient may say they still see folding in a close-up selfie, while there may be significant improvement in a standard profile photo. In this case, how the viewing angle changes perception is shown to the patient.

At the control appointment, photos are first compared, then the patient is re-evaluated under the same lighting, not in a mirror. Mirror image and phone camera provide different perspectives, so they are not standalone decision tools. In medical aesthetics, a good result is not just about performing treatment, but about accurately measuring the result and revising the plan if necessary.

Brief Clinical Summary for 2026

In 2026, the trend in double chin treatment is to create a layered plan according to anatomy, rather than trying to solve everyone's problem with a single device. Recommendations given without separately reading fat, skin, muscle, and bone support will be incomplete. The patient's social calendar, recovery tolerance, and long-term care desire are also part of the medical decision. Therefore, a good double chin consultation is not just about choosing a procedure, but about honestly discussing realistic goals, the correct sequence, follow-up schedule, and, if necessary, the surgical limit.

Final Reminder for Patient Safety

Safety in double chin treatment begins with accurate anatomical diagnosis and is completed with accessible post-procedure follow-up. The patient should know when they are experiencing normal recovery and when they need to call the clinic. Severe pain, unilateral weakness, increasing redness, fever, or unexpected difficulty swallowing should be evaluated without delay.

Scientific Sources

1. Jones DH, Carruthers J, Joseph JH, et al. REFINE-1, a randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction. Dermatologic Surgery. 2016;42(1):38-49.
2. Humphrey S, Sykes J, Kantor J, et al. ATX-101 for reduction of submental fat: A phase III randomized controlled trial. Dermatologic Surgery. 2016;42(1):17-25.
3. Alster TS, Tanzi EL. Microfocused ultrasound for nonsurgical skin tightening: A comprehensive review. Lasers in Surgery and Medicine. 2020;52(7):589-597.
4. Friedmann DP, Bourelly PE, Vega VL. Treatment of the submentum and jawline with synchronous ultrasound parallel beam technology (Sofwave): A prospective clinical study. Dermatologic Surgery. 2022;48(11):1198-1204.
5. Lee JC, Lorenc ZP. Polydioxanone (PDO) thread lifting in the submental and jawline regions: Clinical outcomes and complications. Dermatologic Surgery. 2019;45(8):1063-1071.
6. Levy PM. The Nefertiti lift: A new technique for specific recontouring of the jawline. Journal of Drugs in Dermatology. 2007;6(11):1090-1093.
7. de Almeida AT, Romiti A, Carruthers JD. The facial platysma and its underappreciated role in lower face dynamics and contour. Dermatologic Surgery. 2017;43(8):1042-1049.
8. Werschler WP, Bertucci V, Few JW, et al. Microfocused ultrasound with visualization for the noninvasive treatment of the décolletage: Clinical study. Aesthetic Surgery Journal. 2020;40(NP145):155-163.
9. Kapicıoğlu Y, Sarac G, Cenk H. Polycaprolactone (PCL) thread lifting in submental and jawline rejuvenation: 12-month follow-up. Journal of Cosmetic Dermatology. 2018;17(6):1085-1090.
10. Vleggaar D, Fitzgerald R, Lorenc ZP, et al. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. Journal of Drugs in Dermatology. 2014;13(4 Suppl):s44-s51.

Conclusion and Contact

Non-surgical double chin treatment is an area that can yield very satisfying results with proper patient selection, accurate anatomical diagnosis, and the correct combination protocol. However, we must also acknowledge that no single device or single injection is equally successful in every patient. The most fundamental lesson I have learned in my 30+ years of medical aesthetic experience is this: "Listen to the patient's anatomy, then choose the treatment."

When planning treatment with you during consultation: (1) detailed anatomical examination; (2) determining your submentum type (fat/skin/platysma/combination); (3) evaluating your age, BMI, phototype, expectations; (4) a personalized combination protocol for you; (5) realistic result expectation calibration; (6) transparent referral if surgical options are needed — these six steps are my clinical standard.

Dr. Hamza Gemici — Medical aesthetic specialist, graduate of Ondokuz Mayıs University Faculty of Medicine, 30+ years of medical and clinical experience, ORCID 0009-0007-8058-2774. For consultation and appointment, WhatsApp 0532 344 82 16 or contact page.

This content is for informational purposes only and does not constitute medical advice. Each patient's anatomy, age, expectations, and systemic condition are different; treatment decisions are always made after a clinical examination. The spectrum of side effects and risk assessment are detailed during consultation. The clinical cases shared in this guide are anonymized and published with patient consent. Visual results vary from person to person.